3rd Annual Pharmacovigilance & Drug Safety Summit

3rd Annual Pharmacovigilance & Drug Safety Summit

Staying up to date with Regulation, Signal and Risk Management during the Covid-19 Pandemic

Berlin, Germany
October 8th–9th, 2020

Conference Overview

As Pharmacovigilance systems are changing significantly around the world, it is very important companies remain updated at all times. Adding to this the rising demand for drugs, the amplified need for novel therapeutics development via extensive clinical trials and the world population growth made drug manufacturers to start to pay more attention to Pharmacovigilance field as public anxiety about safety increases.

Furthermore the growth of artificial intelligence and combination products, signal management is ever more important. It is important to meet the right people and understand the regulatory changes with IDMP, combo products as well as being prepared for inspections and audits.

On this B2B event participants will have the chance to learn more about this challenging era and the latest developments in Pharmacovigilance and Drug Safety with the main key players in this field.

This event will be focusing on trends on Regulatory Challenges, Signal Detection, Data Management, Risk management, Audit & Inspection and New Technology applied to Pharmacovigilance procedures.

We invite you to discuss and debate these challenges in a dialogue amongst top professionals in Pharmacovigilance.

Key topics:

  • Impacts of PV on Covid-19
  • Improving Signal surveillance
  • Artificial Intelligence in Signal Detection
  • Combination products – Regulation, trials, and risk management
  • The role of data mining in Pharmacovigilance and its benefits
  • IDMP standards and strategy
  • Developing a pharmacovigilance risk management plan with a risk minimization action plan (RiskMAP) for high risk products
  • Understanding how Artificial Intelligence is transforming pharmacovigilance
  • Evaluation of quality and manufacturing in production
  • Audits and Inspections
  • Strengthening Pharmacovigilance quality management system
  • Impact of AI in Pharmacovigilance
  • Upcoming regulatory changes
  • Signal management
  • Application of data analytics in Pharmacovigilance processes to increase speed of signal detection

Who Should Attend:

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, and Managers specialising in:

  • Assurance & Compliance
  • Quality Assurance
  • Quality Control
  • Data Analysis
  • Pharmacovigilance
  • Pharmacology
  • Pharmacoepidemiology
  • Epidemiology
  • Medical Information
  • Health Outcomes
  • Clinical Data Management
  • MedDRA
  • PV Agreements
  • PSMF
  • CAPA
  • QPPV
  • Medical Affairs
  • Adverse Drug Reactions
  • Drug/Product Safety
  • Drug Development
  • RMPs
  • GPvP
  • Clinical Pharmacology
  • Clinical Safety
  • Clinical Trials
  • Clinical Trial Management
  • Clinical Development
  • Clinical Research
  • Risk Management
  • Research & Development
  • Patient Safety
  • Signal Detection
  • Signal Management
  • Safety Surveillance
  • Safety Databases
  • Safety Evaluation
  • Outcome Research
  • Regulatory Affairs and Compliance
  • Data management and data mining
  • Benefit-Risk Assessment
  • Regulatory Submissions
  • PV Governance
  • Safety Management
  • Pharmacovigilance Operations
  • PV Inspection and Audit Readiness
  • Patient Support Programs
  • Medical Safety
  • Medical Product Safety Assessment
  • Phase IV/Postmarketing Safety

Target Audience:

  • International and regional health authorities and regulators
  • Pharmaceutical, Vaccines, & Biotechnology companies 
  • Clinical Research Organization (CRO) service providers 
  • Business Process Outsourcing (BPO) service providers 
  • Risk Management Software developers 
  • Pharmacovigilance Audit Firm’s 
  • Pharmacovigilance consultancy service providers
  • Contract Research Organizations
  • Adverse Event/Case Management Service Providers 
  • Safety Database Providers for Case Management 
  • Healthcare/Pharmacovigilance Consultants 
  • Healthcare Translation Agencies 
  • Technology Vendors/Portal Service Provider

For any enquiry on regards to special offers & group discounts please contact us directly at:

Previous Event

previous arrow
previous arrow
next arrow
next arrow
previous arrownext arrow


Media Partners

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond.

Labiotech Insider’ is a membership program that helps biotech and biopharma leaders, investors, researchers and enthusiasts stay ahead with access to timely information about the European biotech ecosystem. Members also have exclusive access to events featuring biotech thought leaders and decision makers. Join the Insider community to support quality journalism and help Labiotech build a successful European biotech ecosystem! Benefit from a 30-day free subscription now.
Event Schedule
Event Speakers
Individual Registration
Delegate package + VAT
Group Registration
Delegate package + VAT